Sunrise has partnered with Prevent Dementia to bring together research on mild-life risk factors for Alzheimer’s disease with Sunrise’s sleep monitoring expertise.

The PREVENT Dementia Research Programme aspires to enhance the ability to predict individuals at the highest risk of developing dementia, ultimately leading to more effective strategies for preventing or mitigating the onset of this condition. 

At the core of this partnership is the exploration of the link between sleep disturbances and dementia development. Emerging evidence suggests that sleep issues, such as sleep fragmentation, abnormal sleep duration, and obstructive sleep apnea, might be associated with cognitive decline and dementia. Identifying the prevalence and severity of unrecognized obstructive sleep apnea in a middle-aged cohort enriched for increased later-life dementia risk is crucial. As sleep is a modifiable behavior, and given the treatability of sleep apnea, it is indeed an important potential target for early interventions in dementia.

Sunrise will provide up to 250 participants in the PREVENT study with the Sunrise sensor, a device designed to detect sleep apnea by measuring mandibular jaw movements. It will be used for long-term monitoring of participants’ sleep patterns, focusing on mid-life.

Led by Craig Ritchie, MD, PhD, a professor at the University of Edinburgh (UK), and Yves Dauvilliers, MD, PhD, a professor at the University of Montpellier (France), the study will be recruiting participants from the University of Edinburgh and Imperial College London. Their collaborative efforts, centered around data from Sunrise, are poised to pave the way for innovative approaches to early dementia intervention and cognitive health preservation.